ADMA Biologics Stock Investing

ADMA
 Stock
  

USD 3.36  0.13  4.02%   

Investing in stocks, such as ADMA Biologics, is an excellent way to grow wealth. For long-term investors, stocks are a good investment even during periods of the market volatility - a stock market downturn means that many stocks are on sale. The event calendar will help you understand the most critical current and past headlines together with many other corporate specific events such as SEC filings, dividends, and regulatory reporting available to the public.
  
Right investment tools help us make smart, informed decisions about our financial future, and using inadequate tools to drive your investment process almost always guarantees terrible results. However, making the right decision on what to use for your ADMA Biologics analysis can be a painful and complicated process. Traditionally, when people think of investment tools, they usually think of a brokerage account that enables investors to buy or sell ADMA Biologics or other financial instruments. Most brokerage firms have research tools, but most of these tools are either not very sophisticated or very difficult to apply for retail investors interested in ADMA Biologics.
Being informed about the market onlook and anticipating its possible future direction always helps investors rip off the higher ROI. Unlike 30 years ago, retail investors have a wealth of information at their fingertips about the stock market, and some may even say they have too much. All the investing-related noise out there is simply impossible for the average lay investor to process. This is especially true if you want to build and manage a diversified portfolio comprised mainly of individual stocks. To originate a well-balanced portfolio requires access to reliable, expert-level sources of actionable information about equities such as ADMA Biologics.
Far too much social signal, news, headlines, and media speculation about ADMA Biologics that are available to investors today. That information is available publicly through ADMA Biologics media outlets and privately through word of mouth or via ADMA Biologics internal channels. However, regardless of the origin, that massive amount of ADMA Biologics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ADMA Biologics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ADMA Biologics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ADMA Biologics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ADMA Biologics alpha.

ADMA Biologics Stock Historical Chart

Most investors accept the general idea that the market moves back and forth in trends. These trends are simply referred to as bull and bear market cycles. Each bull market begins after a day that signals the beginning of a new uptrend, whereas every bear market starts after the long-term downward trend is projected forward. Using ADMA Biologics stock market historical data and studying specific examples from the stock market past, makes it easier to put current market moves in context, while making an informed buy or sell decision.

ADMA Biologics Investment Analysis Tools

This is a quick snapshot of ADMA Biologics research areas. You can expand your research by examining different market driven as well as company-specific characteristics using powerful cross-assets modules such as watchlist analyzer, correlation inspector, opportunity browser, portfolio optimizer and many other powerfull tools.
Quote & Profile

Quote & Profile

ADMA Biologics profile, quote, and daily performance
Earnings Estimate

Earnings Estimate

Historical and projected earnings estimates for ADMA Biologics
Updated
Fundamental Analysis

Fundamental Analysis

Fundamentals and financial ratios for ADMA Biologics
Event Calendar

Event Calendar

Calendar of corporate events and headlines for ADMA Biologics
Updated
Technical Analysis

Technical Analysis

Basic technical indicators and analysis for ADMA Biologics
Momentum Indicators

Momentum Indicators

View over 20 different momentum indicators for ADMA Biologics
Updated
Alpha Analysis

Alpha Analysis

Instant market alpha and beta exploration for ADMA Biologics
Chance of Bankruptcy

Chance of Bankruptcy

ADMA Biologics chance of financial distress in the next 2 years
Pattern Recognition

Pattern Recognition

View over 30 different ADMA Biologics historical pattern-recognition indicators
Current Valuation

Current Valuation

ADMA Biologics valuation after adjusting for liquid asset and debt
News and Headlines

News and Headlines

ADMA Biologics current and past headlines and price impact
Bollinger Bands

Bollinger Bands

Analyze ADMA Biologics Bollinger Bands indicator to determine target price movement boundaries
Historical Volatility

Historical Volatility

ADMA Biologics volatility and risk analysis compared to market
Updated
Correlation With Market

Correlation With Market

ADMA Biologics correlation with market
Backtesting

Backtesting

Backtesting to check gain and loss over specified period
Compare to peers

Compare to peers

ADMA Biologics in the context of related companies
Management

Management

ADMA Biologics leadership and management evaluation
Performance

Performance

Risk-adjusted expected returns and performance analysis
Risk-adjusted Advice

Risk-adjusted Advice

Personalized buy or sell advice on ADMA Biologics
Power Widgets

Power Widgets

Macroaxis widgets syndication for ADMA Biologics
Price Prediction

Price Prediction

Basic ADMA Biologics price forecast based on headlines and hype
Updated
Analyst Recommendations

Analyst Recommendations

Analyst recommendations and target price estimates for ADMA Biologics
Piotroski F Score

Piotroski F Score

Piotroski F Score is based on binary analysis strategy of ADMA Biologics
Fundamental History

Fundamental History

ADMA Biologics history of fundamentals from various financial
Revenue

Revenue

Relative ADMA Biologics revenue analysis
Updated
Net Loss Analysis

Net Loss Analysis

ADMA Biologics loss analysis for the latest period
Financial Leverage

Financial Leverage

Effects of financial leverage on ADMA Biologics operations
Balance Of Power

Balance Of Power

Daily balance of power indicator of ADMA Biologics
Semi-Deviation

Semi-Deviation

Current Semi-Deviation of ADMA Biologics
Price History

Price History

ADMA Biologics daily price history and news impact
Updated
Pair Correlation

Pair Correlation

Correlation between ADMA Biologics and Anheuser Busch
ADMA vs. NWHUF

ADMA vs. NWHUF

Fundamentals comparison between ADMA Biologics and Northwest Healthcare

ADMA Biologics Upcoming and Recent Events

In most cases, entities such as ADMA Biologics have five main reporting periods - one for each fiscal quarter and one for the fiscal year. The fiscal year for most companies runs from January 1st to December 31st. The standard calendar quarters that make up the year are usually January, April, July, and October. These dates are essential for ADMA Biologics stakeholders because ADMA Biologics provides information to its current and potential investors on these particular dates. ADMA Biologics prospectus issued under the SEC's guidelines is a legal declaration of facts and statements to ensure that ADMA Biologics investors are not misled.
Upcoming Quarterly Report24th of March 2022
Next Financial Report11th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End24th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

ADMA Biologics Corporate SEC Filings

SEC filings are required by law to meet strict transparency standards and other critical legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial ADMA Biologics specific information freely available to individual and institutional investors to make a timely investment decision.
10th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
28th of June 2022
Unclassified Corporate Event
View
13th of June 2022
Other Events
View
Please continue to Trending Equities. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.